To the Editor: Davis and colleagues recently described outcomes for Indigenous and non-Indigenous people in the Northern Territory who received antiviral therapy for chronic hepatitis C virus (HCV) infection.1 They showed similar outcomes when comparing eight Indigenous people with 88 non-Indigenous people who were assessed for sustained virological response (SVR) after interferon-based treatment — SVR was achieved by 50% and 61%, re
- Careers centre
- MJA Open
- Job Search
Treatment outcomes for Indigenous and non-Indigenous inmates with hepatitis C in New South Wales prisons
Jeffrey J Post, Andrew R Lloyd and Denise Monkley
Med J Aust 2013; 199 (7): 464.
Jeffrey J Post, Infectious Diseases Physician1,2
Andrew R Lloyd, Infectious Diseases Physician2,3
Denise Monkley, Service Director2
Davis JS, Kulatunga AC, Hajkowicz K. Outcomes for Indigenous and non-Indigenous patients who access treatment for hepatitis C in the Top End of the Northern Territory [letter]. Med J Aust 2013; 199: 23.
Boonwaat L, Haber PS, Levy MH, Lloyd AR. Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C. Med J Aust 2010; 192: 496-500.
Lloyd AR, Clegg J, Lange J, et al. Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting. Clin Infect Dis 2013; 56: 1078-1084.
Australian Bureau of Statistics. Prisoners in Australia. Canberra: ABS, 2013. (ABS Cat. No. 4517.0.) http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4517.02012?Open Document (accessed Jul 2013).
The full contents of this page are only available to subscribers.
Log in to keep reading
* Required information